非器械腰椎融合联合BMP治疗老年腰椎管狭窄伴滑脱
本研究回顾性比较了老年腰椎管狭窄伴滑脱患者中,非器械后外侧融合联合rhBMP-2与器械融合的效果。结果显示非器械rhBMP-2组再手术率更低,疼痛和ODI改善更显著,额外随访次数更少。
要点
- 非器械rhBMP-2融合组再手术率显著低于器械融合组(3.4% vs 17.6%,P=0.048)。
- 非器械组3个月和1年疼痛改善均显著优于器械组。
- 非器械组ODI改善和额外随访次数显著优于器械组。
核心结论
- 在老年腰椎管狭窄伴滑脱患者中,基于本研究临床结果,非器械后外侧融合联合rhBMP-2是器械融合的可行替代方案。
研究设计与样本
- 回顾性研究,纳入93例患者,来自单一神经外科私人执业医生15年期间的治疗。
- 非器械后外侧融合联合rhBMP-2组59例(年龄>65岁),器械融合无rhBMP-2组34例。
- 采用t检验和χ2检验比较再手术率、疼痛改善、ODI评分和额外随访次数。
主要发现
- 非器械rhBMP-2组再手术率显著低于器械融合组(3.4% vs 17.6%,P=0.048)。
- 非器械rhBMP-2组3个月疼痛改善显著高于器械组(8.1 vs 6.0,P<0.001,95%CI 1.2至3.0)。
- 非器械rhBMP-2组1年疼痛改善显著高于器械组(7.25 vs 5.6,P=0.030,95%CI 0.3至3.1)。
- 非器械rhBMP-2组ODI改善显著高于器械组(51 vs 42.8,P<0.001,95%CI 4.7至11.6)。
- 非器械rhBMP-2组每患者平均额外随访次数显著低于器械组(0.068 vs 1.23,P<0.001,95%CI 0.59至1.75)。
临床怎么用
- 对于老年腰椎管狭窄伴滑脱患者,非器械后外侧融合联合rhBMP-2可作为器械融合的可行替代方案。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study examined the use of noninstrumented posterolateral lumbar fusion with bone morphogenetic protein (BMP) and compared its effectiveness with that of instrumented fusion for the treatment of lumbar spinal stenosis (LSS) with spondylolisthesis in elderly patients. METHODS: This study was a retrospective review of 93 patients treated in a single-surgeon neurosurgical private practice over a 15-year period. Fifty-nine patients over the age of 65 who underwent noninstrumented posterolateral fusion with rhBMP-2 (Infuse) for LSS with spondylolisthesis were compared with 34 patients who underwent instrumented fusion without rhBMP-2. Outcomes in terms of reoperation rate, pain improvement, Oswestry Disability Index (ODI) score, and number of extra follow-up visits due to persistent problems were characterized by the use of t tests and χ2 tests. RESULTS: The reoperation rate in the noninstrumented rhBMP-2 fusion group was significantly lower than in the instrumented fusion group (17.6% vs. 3.4%, P = 0.048). The mean pain improvement was significantly higher in the noninstrumented rhBMP-2 group at 3 months (8.1 vs. 6.0, P < 0.001, 95% confidence interval [CI] 1.2 to 3.0) and at 1 year (7.25 vs. 5.6, P = 0.030, 95% CI 0.3 to 3.1). The ODI score improvement was significantly higher in the noninstrumented rhBMP-2 group (51 vs. 42.8, P < 0.001, 95% CI 4.7 to 11.6). The mean number of additional follow-up visits per patient was significantly lower in the noninstrumented rhBMP-2 group (0.068 vs. 1.23, P < 0.001, 95% CI 0.59 to 1.75). CONCLUSION: Noninstrumented posterolateral lumbar fusion with rhBMP-2 in elderly patients with LSS and spondylolisthesis is a viable alternative to instrumented fusion based on clinical outcomes measured in this study.
引用
- Bindal S, Bindal SK, Bindal M, et al. Noninstrumented Lumbar Fusion with Bone Morphogenetic Proteins for Spinal Stenosis with Spondylolisthesis in the Elderly. World Neurosurg. 2019. PMID: 30904805. doi:10.1016/j.wneu.2019.02.251
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。